Changchun High-Tech Industry (000661.SZ) subsidiary GenSci155 Injection clinical trial application approved
Changchun High-Tech Industry (000661.SZ) announced that recently, its subsidiary Changchun GeneScience Pharmaceutical Co., Ltd. ("GeneScience Pharmaceutical") received the Drug Clinical Trial Approval Notice issued by the National Medical Products Administration, and the domestic production drug registration clinical trial application for GeneScience Pharmaceutical's GenSci155 Injection has been approved. The drug is intended for the prevention of bronchopulmonary dysplasia (BPD) in premature infants and the treatment of primary insulin-like growth factor-1 deficiency (PIGFD), with subcutaneous injection as the route of administration.
Changchun High-Tech Industry (000661.SZ) announced that recently, its subsidiary Changchun GeneScience Pharmaceutical Co., Ltd. ("GeneScience Pharmaceutical") received the Drug Clinical Trial Approval Notice issued by the National Medical Products Administration, and GeneScience Pharmaceutical's application for registration of a domestic-produced drug clinical trial for GenSci155 Injection has been approved. The drug is intended for the prevention of bronchopulmonary dysplasia (BPD) in premature infants and the treatment of primary insulin-like growth factor-1 deficiency (PIGFD), with subcutaneous injection as the route of administration.
Related Articles
Sinolink: A-share "imperfect bottom" rebound front-run; recommend allocation around three approaches including oversold rebound
ALCO HOLDINGS (00328) proposes to place up to 57,278,400 shares at a discount of approximately 17.7% to raise net proceeds of approximately HK$21 million
MICROPORT(00853): Jonathan W. Chen Appointed as Executive Director
Sinolink: A-share "imperfect bottom" rebound front-run; recommend allocation around three approaches including oversold rebound
ALCO HOLDINGS (00328) proposes to place up to 57,278,400 shares at a discount of approximately 17.7% to raise net proceeds of approximately HK$21 million
MICROPORT(00853): Jonathan W. Chen Appointed as Executive Director
